financetom
Business
financetom
/
Business
/
McCormick's Fiscal Q3 Adjusted Earnings Rise, Net Sales Unchanged; Fiscal 2024 Guidance Updated
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
McCormick's Fiscal Q3 Adjusted Earnings Rise, Net Sales Unchanged; Fiscal 2024 Guidance Updated
Oct 2, 2024 10:03 PM

07:02 AM EDT, 10/01/2024 (MT Newswires) -- McCormick ( MKC ) reported fiscal Q3 adjusted earnings Tuesday of $0.83 per diluted share, up from $0.65 a year earlier.

Analysts polled by Capital IQ expected $0.67.

Net sales for the quarter ended Aug. 31 were $1.68 billion, unchanged from a year earlier.

Analysts surveyed by Capital IQ expected $1.67 billion.

The company now expects fiscal 2024 adjusted EPS of $2.85 to $2.90, compared with its prior guidance of between $2.80 and $2.85. Analysts polled by Capital IQ expect $2.87.

Net sales for the fiscal year are now expected to range from 1% growth to a 1% decline, compared with its earlier forecast of a flat to a 2% decline.

Shares of McCormick ( MKC ) were up 1.8% in recent Tuesday premarket activity.

Price: 83.80, Change: +1.50, Percent Change: +1.82

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Monogram Technologies Says US FDA Grants 510(k) Clearance for Monogram mBos TKA System
Monogram Technologies Says US FDA Grants 510(k) Clearance for Monogram mBos TKA System
Mar 17, 2025
08:16 AM EDT, 03/17/2025 (MT Newswires) -- Monogram Technologies ( MGRM ) said Monday that its robotic-assisted total knee arthroplasty system, the Monogram mBos TKA System, has received a 510(k) clearance from the US Food and Drug Administration. Monogram Technologies ( MGRM ) said the approval allows to market the device, subject to the requirements of the Federal Food, Drug,...
Stellantis invests $41 million in Italy to make EV engine parts
Stellantis invests $41 million in Italy to make EV engine parts
Mar 17, 2025
MILAN (Reuters) - Automaker Stellantis is investing 38 million euros ($41 million) in its Verrone plant in Northern Italy to manufacture parts for electric engines for its upcoming small-size models, it said on Monday. The plant will manufacture steel components for electric drive modules Stellantis ( STLA ) currently makes in other European facilities, the company said in a statement,...
Market Chatter: Amazon to Add Premium Tier of Alexa Devices
Market Chatter: Amazon to Add Premium Tier of Alexa Devices
Mar 17, 2025
08:25 AM EDT, 03/17/2025 (MT Newswires) -- Amazon.com ( AMZN ) plans to expand its Alexa device line with a premium tier in a bid to offer consumers more choices, Bloomberg reported Monday, citing the company's head for devices and services Panos Panay. Panay told the news outlet that the voice assistant's new artificial intelligence operating system, Alexa+, will be...
Precision Says its Investigational New Drug Application for Hepatitis B Treatment Gets US FDA's Clearance
Precision Says its Investigational New Drug Application for Hepatitis B Treatment Gets US FDA's Clearance
Mar 17, 2025
08:22 AM EDT, 03/17/2025 (MT Newswires) -- Precision BioSciences ( DTIL ) said Monday its investigational new drug application for PBGENE-HBV in vivo gene editing program has received the US Food and Drug Administration's clearance to treat chronic hepatitis B. The company is in final stages of US site activation to start enrolling participants in its Eliminate-B study in the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved